Answers are grounded in this paper and cite their sources.
The first nonpeptidic, noncovalent inhibitors of the cysteine protease cathepsin S (CatS) are described. Electronic database searching using the program DOCK generated a screening set of potential CatS inhibitors from which two lead structures were identified as promising starting points for a drug discovery effort. Lead optimization afforded potent (IC(50) < 50 nM) and selective inhibitors of CatS demonstrating cellular activity and reversibility of enzyme inhibition.
No takes yet. Share an insight, caveat, or question.
Thurmond et al. (2004) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: